BR9712436A - Polìmeros polianiÈnicos como adjuvantes para imunização da mucosa - Google Patents

Polìmeros polianiÈnicos como adjuvantes para imunização da mucosa

Info

Publication number
BR9712436A
BR9712436A BR9712436-2A BR9712436A BR9712436A BR 9712436 A BR9712436 A BR 9712436A BR 9712436 A BR9712436 A BR 9712436A BR 9712436 A BR9712436 A BR 9712436A
Authority
BR
Brazil
Prior art keywords
acid
polyanionic polymers
adjuvants
salts
mucosal
Prior art date
Application number
BR9712436-2A
Other languages
English (en)
Inventor
Luuk Hilgers
Original Assignee
Dimminaco Ag Sa Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dimminaco Ag Sa Ltd filed Critical Dimminaco Ag Sa Ltd
Publication of BR9712436A publication Critical patent/BR9712436A/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/39Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/54Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541Mucosal route
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55555Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)

Abstract

Patente de Invenção: <B>"POLìMEROS POLIANIÈNICOS COMO ADJUVANTES PARA IMUNIZAçãO DA MUCOSA"<D>. São divulgados adjuvantes mucosais para vacinas compreendidos de polímeros polianiónicos solúveis em água que têm unidades constitucionais aniónicas obtidas a partir de ácidos tais como ácido acrílico, ácido metacrílico, ácido maléico, ácido fumárico, ácido etilsulfónico, ácido vinilsulfúrico, ácido vinilsulfónico, ácido estirenossulfónico, ácido vinilfenilsulfúrico, ácido 2-metacriloiloxietano sulfónico, ácido 3-metacriloilóxi-2-hidroxipropanossulfónico, ácido 3-metacril amido-3-metilbutanóico, ácido acrilamidometilpropanossulfónico, ácido vinilfosfórico, ácido 4-vinilbenzóico, ácido 3-vinil oxipropano-1-sulfónico, ácido N-vinilsuccinimídico e sais dos anteriores. Os polímeros polianiónicos podem ainda ter unidades de repetição constitucionais hidrófobas tais como alquilésteres, cicloalquilésteres, hidroxialquilésteres, éteres, glicóis, grupos aromáticos e sais dos mesmos. Também são divulgados aqui o uso de polímeros polianiónicos da presente invenção para e indução ou para a melhoria de respostas inunológicas mucosais, assim como de vacinas não parenterais que contenham o polímero polianiónico da presente invenção.
BR9712436-2A 1996-10-24 1997-10-23 Polìmeros polianiÈnicos como adjuvantes para imunização da mucosa BR9712436A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9622159.3A GB9622159D0 (en) 1996-10-24 1996-10-24 Polyanionic polymers as adjuvants for mucosal immunization
PCT/EP1997/005861 WO1998017310A2 (en) 1996-10-24 1997-10-23 Polyanionic polymers as adjuvants for mucosal immunization

Publications (1)

Publication Number Publication Date
BR9712436A true BR9712436A (pt) 2000-10-24

Family

ID=10801896

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9712436-2A BR9712436A (pt) 1996-10-24 1997-10-23 Polìmeros polianiÈnicos como adjuvantes para imunização da mucosa

Country Status (11)

Country Link
US (1) US6610310B2 (pt)
EP (1) EP0934077B1 (pt)
JP (1) JP4344014B2 (pt)
AT (1) ATE360440T1 (pt)
AU (1) AU717349B2 (pt)
BR (1) BR9712436A (pt)
CA (1) CA2269780C (pt)
DE (1) DE69737658T2 (pt)
ES (1) ES2285741T3 (pt)
GB (1) GB9622159D0 (pt)
WO (1) WO1998017310A2 (pt)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040116350A1 (en) * 2001-09-17 2004-06-17 Paul Wentworth Jr Methods and compositions relating to hydrogen peroxide and superoxide production by antibodies
US20040157280A1 (en) * 2001-09-17 2004-08-12 Paul Wentworth Antibody mediated ozone generation
US20050129680A1 (en) * 2001-09-17 2005-06-16 Paul Wentworth Antimicrobial activity of antibodies
MX339524B (es) 2001-10-11 2016-05-30 Wyeth Corp Composiciones inmunogenicas novedosas para la prevencion y tratamiento de enfermedad meningococica.
CA2505923A1 (en) * 2002-11-14 2004-05-27 Novartis Ag Antibody-or neutrophil-mediated ozone generation
GB0313916D0 (en) 2003-06-16 2003-07-23 Glaxosmithkline Biolog Sa Vaccine composition
JP4860109B2 (ja) * 2003-12-26 2012-01-25 バイオリーダース・コーポレイション ポリガンマグルタミン酸を含む免疫増強用組成物
DE102006047617B4 (de) * 2006-10-09 2008-11-27 Clariant International Limited Verfahren zur Herstellung basischer (Meth)acrylamide
US20090017064A1 (en) * 2007-07-10 2009-01-15 Wyeth Methods and Compositions for Immunizing Pigs Against Porcine Circovirus
FR2922767B1 (fr) 2007-10-24 2009-12-18 Seppic Sa Procede de preparation d'une composition vaccinale comprenant au moins un antigene et au moins un adjuvant.
MX2010005014A (es) 2007-11-06 2010-06-30 Wyeth Llc Vacuna viva avirulenta de mycoplasma hyopneumoniae con adyuvante.
EP2062594A1 (en) * 2007-11-21 2009-05-27 Wyeth Farma, S.A. Bluetongue virus vaccine and immunogenic compositions, methods of use and methods of producing same
DE102008017216B4 (de) * 2008-04-04 2013-08-14 Clariant International Ltd. Kontinuierliches Verfahren zur Herstellung von Fettsäureamiden
TW201010719A (en) * 2008-08-19 2010-03-16 Wyeth Corp Immunological composition
GB0907989D0 (en) 2009-05-08 2009-06-24 Hybrid Systems Ltd Multivalent adjuvant display
RU2531234C2 (ru) 2009-06-22 2014-10-20 ВАЙЕТ ЭлЭлСи КОНЪЮГАТ ПОЛИСАХАРИД-БЕЛОК ДЛЯ ИНДУЦИРОВАНИЯ ИММУННОГО ОТВЕТА И ЗАЩИТЫ ПРОТИВ ИНФЕКЦИИ Staphylococcus aureus, СПОСОБЫ ПОЛУЧЕНИЯ КОНЪЮГАТА (ВАРИАНТЫ), КОМПОЗИЦИЯ, СОДЕРЖАЩАЯ КОНЪЮГАТ И СПОСОБЫ ИНДУЦИРОВАНИЯ ИММУННОГО ОТВЕТА И ПРЕДОТВРАЩЕНИЯ ИНФЕКЦИИ Staphylococcus aureus
TWI469789B (zh) 2009-06-22 2015-01-21 Wyeth Llc 金黃色葡萄球菌抗原之免疫原性組合物
DE102009031059A1 (de) 2009-06-30 2011-01-05 Clariant International Ltd. Vorrichtung zur kontinuierlichen Durchführung chemischer Reaktionen bei hohen Temperaturen
US20110110980A1 (en) 2009-09-02 2011-05-12 Wyeth Llc Heterlogous prime-boost immunization regimen
DE102009042522A1 (de) 2009-09-22 2011-04-07 Clariant International Ltd. Kontinuierliches Umesterungsverfahren
DE102009042523B4 (de) 2009-09-22 2012-02-16 Clariant International Ltd. Vorrichtung und Verfahren zur kontinuierlichen Durchführung heterogen katalysierter chemischer Reaktionen bei hohen Temperaturen
EP2600858A4 (en) 2010-08-04 2014-03-05 Tixupharma SUPRAMOLECULAR COMPLEXES OF POLYANIONIC POLYMERS AND SPERMIDINE FOR WOVEN CARE AND REPAIR
SI3246044T2 (sl) 2010-08-23 2024-06-28 Wyeth Llc Stabilne formulacije antigenov neisseria meningitidis RLP2086
ES2585328T5 (es) 2010-09-10 2022-12-14 Wyeth Llc Variantes no lipidadas de antígenos ORF2086 de Neisseria meningitidis
EP2654784B1 (en) 2010-12-22 2016-12-07 Wyeth LLC Stable immunogenic compositions of staphylococcus aureus antigens
DE102010056564A1 (de) 2010-12-30 2012-07-05 Clariant International Limited Hydroxylgruppen und Estergruppen tragende Polymere und Verfahren zu ihrer Herstellung
DE102010056566A1 (de) * 2010-12-30 2012-07-05 Clariant International Ltd. Kontinuierliches Verfahren zur Veresterung Säuregruppen tragender Polymere
DE102010056565A1 (de) 2010-12-30 2012-07-05 Clariant International Ltd. Verfahren zur Modifizierung Hydroxylgruppen tragender Polymere
SA115360586B1 (ar) 2012-03-09 2017-04-12 فايزر انك تركيبات لعلاج الالتهاب السحائي البكتيري وطرق لتحضيرها
RU2665841C2 (ru) 2012-03-09 2018-09-04 Пфайзер Инк. Композиции neisseria meningitidis и способы их применения
US9120859B2 (en) 2012-04-04 2015-09-01 Zoetis Services Llc Mycoplasma hyopneumoniae vaccine
UA114504C2 (uk) 2012-04-04 2017-06-26 Зоетіс Сервісіз Ллс Комбінована вакцина pcv, mycoplasma hyopneumoniae та prrs
UA114503C2 (uk) 2012-04-04 2017-06-26 Зоетіс Сервісіз Ллс Комбінована вакцина pcv та mycoplasma hyopneumoniae
EP4169929A1 (en) 2012-12-20 2023-04-26 Pfizer Inc. Immunogenic compositions comprising pn-serotype 12f
JP6446377B2 (ja) 2013-03-08 2018-12-26 ファイザー・インク 免疫原性融合ポリペプチド
EP3041502A2 (en) 2013-09-08 2016-07-13 Pfizer Inc. Neisseria meningitidis compositions and methods thereof
MX2016003855A (es) 2013-09-25 2016-08-04 Zoetis Services Llc Composicion de vacuna de circovirus porcino tipo 2b divergente y procedimientos de uso.
RU2723045C2 (ru) 2015-02-19 2020-06-08 Пфайзер Инк. Композиции neisseria meningitidis и способы их получения
IL297740A (en) 2015-05-04 2022-12-01 Pfizer Protein-polysaccharide conjugates of group b streptococcus, methods for preparing the conjugates, immunogenic preparations containing conjugates and their uses
CA3027877A1 (en) * 2016-06-17 2017-12-21 Merial, Inc. Novel immunogenic formulations comprising linear or branched polyacrylic acid polymer adjuvants
US10751402B2 (en) 2016-11-09 2020-08-25 Pfizer Inc. Immunogenic compositions and uses thereof
IL267733B2 (en) 2017-01-31 2023-10-01 Pfizer NEISSERIA MENINGITIDIS preparations and methods therefor
BR112020017715A2 (pt) 2018-03-16 2020-12-29 Zoetis Services Llc Vacinas de peptídeo contra interleucina-31
CN109134724A (zh) * 2018-07-24 2019-01-04 石家庄哈顿生物技术有限公司 一种动物疫苗用聚丙烯酸类聚合物佐剂的研制方法
CA3192786A1 (en) 2020-08-26 2022-03-03 Pfizer Inc. Group b streptococcus polysaccharide-protein conjugates, methods for producing conjugates, immunogenic compositions comprising conjugates, and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4567042A (en) * 1983-06-15 1986-01-28 American Home Products Corporation Inactivated canine coronavirus vaccine
ZA881694B (en) * 1987-03-17 1988-09-06 Akzo N.V. Adjuvant mixture
US5242686A (en) * 1990-11-07 1993-09-07 American Home Products Corporation Feline vaccine compositions and method for preventing chlamydia infections or diseases using the same
EP0532833A1 (en) * 1991-05-28 1993-03-24 Miles Inc. Vaccine for equine rhinopneumonitis
BE1008977A5 (fr) * 1994-12-27 1996-10-01 Solvay Adjuvants pour vaccins.

Also Published As

Publication number Publication date
JP2001507336A (ja) 2001-06-05
DE69737658D1 (de) 2007-06-06
EP0934077B1 (en) 2007-04-25
DE69737658T2 (de) 2008-01-31
JP4344014B2 (ja) 2009-10-14
CA2269780C (en) 2008-12-02
CA2269780A1 (en) 1998-04-30
GB9622159D0 (en) 1996-12-18
AU717349B2 (en) 2000-03-23
WO1998017310A3 (en) 1998-06-18
WO1998017310A2 (en) 1998-04-30
ES2285741T3 (es) 2007-11-16
AU5313398A (en) 1998-05-15
US6610310B2 (en) 2003-08-26
EP0934077A2 (en) 1999-08-11
US20030021793A1 (en) 2003-01-30
ATE360440T1 (de) 2007-05-15

Similar Documents

Publication Publication Date Title
BR9712436A (pt) Polìmeros polianiÈnicos como adjuvantes para imunização da mucosa
ES2563677T3 (es) Composiciones de combinaciones de Neisseria
DK1124541T3 (da) Anvendelse af vandopløselige eller vanddispergerbare polyetherholdige podepolymerisater som overtræksmidler, bindemidler og/eller filmdannende hjælpestoffer til farmaceutiske indgivelsesformer
DK0710117T3 (da) Phosphazen-polyelektrolyter som immunadjuvanser
DE60026742D1 (de) Amphiphile polymere vesikel
BR0314831A (pt) Conjugados de polìmeros com antigenicidade diminuìda, seus métodos de preparação e usos
EP0939093A3 (en) Weatherable copolymers
ATE198980T1 (de) Bioabbaubare polymere zur zelltransplantation
ATE264911T1 (de) Eine universelle immunmodulatorische cytokin- expressierende zelllinie in wartestelling. entsprechende zusammensetzungen und methoden ihrer herstellung und verwendungen
CY1105109T1 (el) Διαδικασια για την παρασκευη μικρου μοριακου βαρους πολυαιθυλενιμινης
AU2535997A (en) Prostate specific antigen oligo-epitope peptide
FR2747046B1 (fr) Nouveaux vaccins issus de plasmovirus
MX2023004101A (es) Inmunoterapia para el tratamiento de cancer.
DK1131408T3 (da) Celler, dyrkningsmetoder og deres anvendelse ved autolog transplantationsbehandling
DK1272652T3 (da) Herpesvirus til immunmodulation
WO2002042426A3 (en) Carrier system for specific artery wall gene delivery
WO2001074845A3 (en) Immunogenic peptides derived from prostate-specific membrane antigen (psma) and uses thereof
DE60130634D1 (de) Identifizierung von antigenen peptiden durch zytotoxische t-lymphozyten aktiviert von dendritischen zellhybriden
CO5280140A1 (es) Antigeno (c42) asociado a tumores
WO2001090220A3 (en) Method for preparing and using supported phosohazenium catalysts
SI20960B (sl) Vakcina, ki obsega seve lactobacillus-a, za zdravljenje ventja prostate in benigne hiperplazije prostate
DE502004002472D1 (de) Alkoxylierte diallylaminderivate enthaltende wasserlösliche oder in wasser dispergierbare polymerisate
EP1731611A3 (en) Eimeria hydrophilic polypeptides as vaccines
EP1674575A3 (en) Ligand for herpes simplex virus entry mediator and methods of use
ES2131879T3 (es) Adyuvante para vacunas.

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: DE ACORDO COM O ART. 37, PUBLIQUE-SE O INDEFERIMENTO DO PRESENTE PEDIDO, TENDO POR BASE O ART. 8O COMBINADO COM OS ARTS. 11 E 13 DA LEI NO 9.279/96.